Using Death Certificate Reports to Find Severe Leptospirosis Cases, Brazil by Spichler, Anne et al.
Using Death 
Certiﬁ  cate Reports 
to Find Severe 
Leptospirosis 
Cases, Brazil
Anne Spichler;*† Daniel Athanazio,‡ 
Marcia Buzzar,* Bronislawa Castro,* 
Erica Chapolla,§ Antonio Seguro,† 
and Joseph M. Vinetz¶
Severe leptospirosis with pulmonary hemorrhage is 
emerging globally. Measures to control leptospirosis through 
sanitation depend on accurate case ﬁ  nding and reporting. 
Rapid death certiﬁ  cate reporting, plus necropsy of persons 
who died of leptospirosis, facilitates public health interven-
tion and could provide an important tool in assessing the 
global burden of leptospirosis.
A
lthough pulmonary involvement has been well rec-
ognized as a major component of leptospirosis (1), 
worldwide attention to severe pulmonary hemorrhagic syn-
drome (SPHS) emerged after an outbreak in rural Nicara-
gua in 1995 in which most cases lacked jaundice and renal 
failure, the classic manifestations of severe leptospirosis 
(2). A report from Peru, where leptospirosis is endemic, 
pointed out that SPHS can complicate human leptospiro-
sis without jaundice or renal failure (a condition known as 
Weil syndrome) (3). Although not well recognized glob-
ally in general clinical practice, SPHS is considered a ma-
jor clinical problem in some leptospirosis-endemic regions, 
ranging from the Andaman and Nicobar Islands (4) to ur-
ban coastal Brazil (5).
Epidemic leptospirosis most commonly occurs after 
ﬂ  ooding in densely populated centers in developing coun-
tries, and it continues to be an important clinical problem 
in urban coastal Brazil. São Paulo is the most populous 
Brazilian state (population ≈40 million). The annual re-
ported incidence of leptospirosis from 1969 through 1996 
was 0.53–1.13 cases per 100,000 inhabitants (6). In the São 
Paulo metropolitan area (population 10.5 million), which 
accounts for 68% of all reported cases, the annual incidence 
of leptospirosis was 1.9–3.7 cases per 100,000 inhabitants 
in the period 1998–2004. During the same period, case-fa-
tality rates varied from 11.0% to 18.0% (Health Municipal-
ity Secretariat of São Paulo, unpub. data). In the São Paulo 
urban setting, SPHS is a common feature of leptospirosis. 
A case series of São Paulo patients with leptospiral SPHS 
found that 23 (55%) of 42 patients died from this disease 
from 1994 through 1997 (7).
The Study 
In 2004, PRO-AIM (Program for Improvement of 
Death Cause Information in São Paulo, abbreviated from 
the Portuguese name) was initiated in the São Paulo metro-
politan area to provide better reporting of causes of death. 
Leptospirosis is a major infectious disease in São Paulo, 
and we started active surveillance for cases of acute renal 
failure and jaundice, pulmonary hemorrhage, or a combina-
tion of both. Detailed questionnaires on clinical and epi-
demiologic features were completed, and necropsies were 
performed to improve identiﬁ  cation of fatal leptospirosis 
cases in São Paulo.
The central component of this program is a death cer-
tiﬁ  cate system. Fatal cases of leptospirosis are a component 
of this registry as a major category. Death certiﬁ  cates with 
any clinical features suggestive of leptospirosis or isolated 
SPHS are referred to the Municipal Health Secretariat of 
São Paulo. The Secretariat analyzes and attempts to con-
ﬁ  rm such cases. Conﬁ  rmation protocols include laboratory 
analysis, clinical and epidemiologic assessment, and veri-
ﬁ  cation by necropsy of case-patients who had pathologic 
features characteristic of leptospirosis in lungs, kidneys, 
and liver. If fatal leptospirosis is conﬁ  rmed within 72 hours, 
public health authorities can be alerted. In a setting of high 
leptospirosis transmission, this step may forestall expan-
sion of an epidemic. Furthermore, the Brazilian experience, 
as well as that of other countries (1), includes a high rate 
of misdiagnosis of leptospirosis and other clinically indis-
tinguishable acute febrile illnesses such as dengue or scrub 
typhus fever. Thus, rapid identiﬁ  cation and conﬁ  rmation of 
fatal leptospirosis are important tools for surveillance, pub-
lic health interventions, and alerting clinicians.
We describe our initial experience of actively seeking, 
identifying, and reporting fatal cases of leptospirosis. Using 
data from January 1, 2004, through August 31, 2006, we 
used a cross-sectional approach to analyze death certiﬁ  cate 
data from the São Paulo metropolitan area. Fatal cases were 
conﬁ  rmed in the laboratory by serologic or immunohisto-
chemical examination, supplemented by epidemiologic 
and clinicopathologic evidence. Pathologic criteria were an 
important adjunct to conﬁ  rm cases because ≈30% of deaths 
of patients hospitalized for leptospirosis occur within 24 
hours, which may preclude serologic diagnosis because of 
delayed antibody responses. Pathologic examination can 
identify constellations of known complications as well as 
unexpected features. In fulminant infection, histopatho-
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logic ﬁ  ndings conﬁ  rm involvement of typical targeted or-
gans such as acute tubular necrosis or interstitial nephri-
tis, acute loss of cohesion of hepatocytes, and pulmonary 
hemorrhage, which is important because, in leptospirosis-
endemic regions, potential leptospirosis patients may have 
had previous infection and thus preexisting antileptospiral 
antibodies (8). We emphasize, however, that pathologic 
criteria are only conﬁ  rmatory if clinical and epidemiologic 
criteria for infection are fulﬁ  lled. In the experience reported 
here, 5 cases (which were included in the laboratory con-
ﬁ  rmation group) were conﬁ  rmed by immunohistochemical 
examination. Leptospiral antigen detection in postmortem 
samples is important for conﬁ  rming the diagnosis (9) but is 
limited by tissue deterioration if there is a prolonged period 
between death and necropsy.
In 2004, 42 (15%) of 285 cases of reported leptospiro-
sis cases were fatal; in 2005, 28 (11%) of 262 cases were 
fatal; and from January 1 through June 2006, 31 (19%) of 
167 cases were fatal. The Table shows the distribution of 
fatal cases from January 2004 through August 2006. Of 
101 fatal cases, 62 were conﬁ  rmed by a combination of se-
rologic and immunohistochemical testing; 15 cases were 
suggested on the basis of clinical, pathologic, and epide-
miologic ﬁ  ndings; and 24 were suspected on the basis of 
strong circumstantial clinical and epidemiologic evidence.
Conclusions
Isolation of leptospires in culture from clinical speci-
mens is the standard for diagnosis but faces logistical ob-
stacles in real-world settings. In our study, only 6 blood 
samples were collected for culture, and they were uninter-
pretable because of contamination. Although not deﬁ  nitive 
for identifying infecting leptospiral serovars, microscopic 
agglutination test titers suggested that the most frequently 
reacting serogroups in São Paulo are Icterohemorrhagiae 
(72%) and Autumnalis (14%).
Of the 101 fatal cases, necropsies were performed for 
42. Of these 42 necropsies, 27 cases were conﬁ  rmed by a 
combination of necropsy and positive serologic test results. 
Fifteen fatal cases were suggested by a combination of nec-
ropsy ﬁ  ndings plus clinical and epidemiologic evidence.
Of all fatal cases conﬁ  rmed by necropsy, Weil syn-
drome with concomitant pulmonary hemorrhage was docu-
mented in 86% of cases in 2004, in 67% in 2005, and in 
69% in 2006. Less common manifestations included Weil 
syndrome without pulmonary hemorrhage, and isolated 
pulmonary hemorrhage (Table).
The frequency of clinical manifestations of severe pul-
monary disease (with or without hemorrhages) was 76% 
among fatal cases and 26% among nonfatal cases. Impor-
tantly, 46% of all patients with severe pulmonary symp-
toms died, a ﬁ  nding that is consistent with the literature 
(1,8).
The system of active death notiﬁ  cation we describe 
can be an important tool to evaluate the emerging compli-
cations of leptospirosis and the global extent of disease due 
to leptospirosis. Nonetheless, this, as well as any system 
of active death certiﬁ  cation notiﬁ  cation, has several limita-
tions. A major problem is increasing the number of necrop-
sies, which may be limited by logistics or cultural norms. 
Increasing the necropsy rate can be aided by prompt re-
sponse through the death certiﬁ  cate notiﬁ  cation system and 
involvement of public health authorities. Another problem 
is the lack of serologic and cultural conﬁ  rmation. Molec-
ular diagnosis would be ideal and could readily be intro-
duced into this system.
The incidence of SPHS seems to have changed else-
where, e.g., in Salvador, another urban area of Brazil, 
where the Copenhageni serovar predominates. Pulmonary 
hemorrhage seems to have newly emerged since the year 
2000 (A. I. Ko, pers. comm.). An active surveillance, death 
certiﬁ  cate–based reporting system represents an important 
tool that should provide further insights into the natural his-
tory and changing clinical manifestations of leptospirosis 
infection in diverse geographic regions in which the disease 
is endemic and epidemic. Systematic reporting focused on 
the most severe cases of leptospirosis has the potential 
for providing a data-driven basis for ministry-level policy 
development, institution of public health control mea-
sures, and quantitative assessment of the global severity of 
leptospirosis.
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Table. Data from death notification reports in the São Paulo, Brazil, metropolitan area, January 2004–August 2006 
Data from reports  2004 2005 2006
Total no. reported leptospirosis cases  285 262 167
Annual incidence per 100,000 inhabitants  2.7 2.4 1.7
Fatality rate, %  15 11 18
Total no. deaths  42 28 31
Fatal cases
  Laboratory confirmed, no. (%)  28 (67)  17 (60)  17 (55) 
  Clinical and epidemiologically assessed, no. (%)  14 (33)  11 (40)  14 (45) 
  Total no. necropsies (%)  14/42 (33)  15/28 (53)  13/31 (41) 
Frequency of concurrent Weil syndrome and pulmonary hemorrhage, no. (%)  12/14 (86)  10/15 (67)  9/13 (69) 
Frequency of Weil syndrome without pulmonary hemorrhage, no. (%)  1/14 (7)  4/15 (27)  3/13 (23) 
Frequency of pulmonary hemorrhage, no. (%)  1/14 (7)  1/15 (6)  1/13 (8) Death Certiﬁ  cate Reports and Severe Leptospirosis
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